Last Updated: November 8, 2026

Patent: 10,392,357

Summary for Patent: 10,392,357

Title:	Glucagon-like peptide 1 modulator and uses thereof
Abstract:	Disclosed herein are novel glucagon-like peptide-1 (GLP-1) modulators and their uses in manufacturing medicaments for the treatment and/or prophylaxis of diseases and/or disorders associated with hyperglycemia.
Inventor(s):	Chein; Rong-Jie (Taipei, TW), King; Klim (Taipei, TW), Lin; Nai-Pin (Taipei, TW), Cheng; Yu-Hong (Taipei, TW)
Assignee:	Acaemia Sinica (Taipei, TW)
Application Number:	15/576,307
Patent Claims:	see list of patent claims

Details for Patent 10,392,357

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Glaxosmithkline Llc	TANZEUM	albiglutide	For Injection	125431	April 15, 2014	10,392,357	2036-06-30
Eli Lilly And Company	TRULICITY	dulaglutide	Injection	125469	September 18, 2014	10,392,357	2036-06-30
Eli Lilly And Company	TRULICITY	dulaglutide	Injection	125469	September 4, 2020	10,392,357	2036-06-30
Sanofi-aventis U.s. Llc	ADLYXIN	lixisenatide	Injection	208471	July 27, 2016	10,392,357	2036-06-30
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.